Top Markets
Coin of the day
F-star Therapeutics, Inc. F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTX
株式のランク #21012
F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... F-star Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to inventing tetravalent bispecific antibodies for the treatment of cancer, particularly within the field of immuno-oncology. The company's primary investigational product, FS118, is currently in a Phase 2 proof-of-concept trial, evaluating its efficacy in head and neck cancer patients who have acquired resistance to PD-1/PD-L1 therapies. F-star is also advancing FS222, a bispecific antibody designed to simultaneously target the costimulatory CD137 receptor and the inhibitory PD-L1 ligand, through its initial Phase 1 human clinical study. Moreover, two additional drug candidates, FS120 and SB 11285, are undergoing Phase 1 clinical evaluation for patients with advanced malignancies. Founded in 2002, F-star Therapeutics, Inc. has its corporate headquarters situated in Cambridge, United Kingdom.
株価
$7.12
最終同期: 2023-03-08
時価総額
$117.03M
変化(1日)
0.00%
変化(1年)
0.00%
GB
取引 F-star Therapeutics, Inc. (FSTX)

カテゴリー

F-star Therapeutics, Inc.(FSTX)の株価履歴
終値の最高値: $6.19 (2023-03-01)

終値の最安値: $7.22 (2021-05-01)
F-star Therapeutics, Inc. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 14.14%
2022 6.74%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH